[RGLS] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
01-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -7.93%
YoY- -2.46%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 18 18 18 18 18 18 204 -80.20%
PBT -16,024 -14,506 -15,835 -21,736 -20,025 -20,015 -19,515 -12.32%
Tax 1 -58 -7 -128 -4 5 4 -60.34%
NP -16,025 -14,448 -15,828 -21,608 -20,021 -20,020 -19,519 -12.33%
Tax Rate - - - - - - - -
Total Cost 16,043 14,466 15,846 21,626 20,039 20,038 19,723 -12.87%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin -89,027.78 -80,266.67 -87,933.33 -120,044.44 -111,227.78 -111,222.22 -9,568.14 342.98%
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS -18.49 -16.68 -21.09 -48.76 -45.34 -45.39 -44.33 -44.20%
EPS Diluted -18.49 -16.68 -21.09 -48.76 -45.34 -45.39 -44.33 -44.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.